Edward Duncan Blair

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

UCL Business Plc operates as a technology transfer company. The company was founded in 2002 and is headquartered in London, the United Kingdom.

AgPlus Diagnostics Ltd. develops technology solutions. It focuses on the development program at Ag and delivers diagnostic platform technology. The firm also offers market applications including human clinical, human non-clinical, sports medicine, veterinary, environmental, and military. The company was founded by Rob Porter and Mateus Symanski in 2006 and is headquartered in Sharnbrook, the United Kingdom.

Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom.